Xuemei Wang

Active 1994–2026

609
Papers
43,785
Citations
109
h-index
477
i10-index

Citations

Citations per year for Xuemei Wang1983: 2 citations1985: 1 citations1986: 1 citations1987: 4 citations1988: 2 citations1989: 6 citations1990: 10 citations1991: 9 citations1992: 10 citations1993: 7 citations1994: 15 citations1995: 16 citations1996: 17 citations1997: 14 citations1998: 18 citations1999: 21 citations2000: 11 citations2001: 30 citations2002: 74 citations2003: 96 citations2004: 96 citations2005: 121 citations2006: 87 citations2007: 144 citations2008: 126 citations2009: 130 citations2010: 176 citations2011: 201 citations2012: 222 citations2013: 189 citations2014: 215 citations2015: 236 citations2016: 242 citations2017: 268 citations2018: 267 citations2019: 951 citations2020: 1,325 citations2021: 1,517 citations2022: 1,513 citations2023: 1,377 citations2024: 2,340 citations2025: 1,286 citations2026: 40 citations1984: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorChina: 4,621 citing papers, 23.8% of this breakdownUnited States: 3,993 citing papers, 20.6% of this breakdownUnited Kingdom: 873 citing papers, 4.5% of this breakdownItaly: 821 citing papers, 4.2% of this breakdownGermany: 767 citing papers, 4% of this breakdownCanada: 514 citing papers, 2.6% of this breakdownFrance: 498 citing papers, 2.6% of this breakdownIndia: 488 citing papers, 2.5% of this breakdownSpain: 472 citing papers, 2.4% of this breakdownAustralia: 446 citing papers, 2.3% of this breakdownJapan: 380 citing papers, 2% of this breakdownNetherlands: 363 citing papers, 1.9% of this breakdown
0%23.8%Other 26.6%

Fields

  • Medicine50.9%
  • Biochemistry, Genetics and Molecular Biology25%
  • Engineering4.1%
  • Computer Science3.5%
  • Materials Science3.3%
  • Environmental Science3.2%
  • Other10%

Topics

  • Gut microbiota and health3.2%
  • Advanced biosensing and bioanalysis techniques1.8%
  • Liver Disease Diagnosis and Treatment1.5%
  • Chronic Lymphocytic Leukemia Research1.4%
  • Acute Myeloid Leukemia Research1.4%
  • Diet and metabolism studies1.2%
  • Other89.5%

Coauthors

All papers

Open in search
  1. Gut microbiota and intestinal FXR mediate the clinical benefits of metformin

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2018 cited by 1,009

  2. The role of the gut microbiome and its metabolites in metabolic diseases

    Authors: , , , , - Protein & Cell 2020 cited by 547

  3. Hyocholic acid species improve glucose homeostasis through a distinct TGR5 and FXR signaling mechanism

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Cell Metabolism 2020 cited by 441

  4. What is the meaning of health literacy? A systematic review and qualitative synthesis

    Authors: , , , , , , , - Family Medicine and Community Health 2020 cited by 674

  5. Dysbiosis gut microbiota associated with inflammation and impaired mucosal immune function in intestine of humans with non-alcoholic fatty liver disease

    Authors: , , , , , , , , - Scientific Reports 2015 cited by 653

  6. Microneedle Patches with Antimicrobial and Immunomodulating Properties for Infected Wound Healing

    Authors: , , , , , , - Advanced Science 2023 cited by 152

  7. Detection of colorectal adenomas with a real-time computer-aided system (ENDOANGEL): a randomised controlled study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - ˜The œLancet. Gastroenterology & hepatology 2020 cited by 376

  8. Intestinal hypoxia-inducible factor 2α regulates lactate levels to shape the gut microbiome and alter thermogenesis

    Authors: , , , , , , , , , , , , - Cell Metabolism 2021 cited by 204

  9. Suppressing the intestinal farnesoid X receptor/sphingomyelin phosphodiesterase 3 axis decreases atherosclerosis

    Authors: , , , , , , , , , , , , , , , , , , - Journal of Clinical Investigation 2021 cited by 126

  10. Perioperative intravenous S-ketamine for acute postoperative pain in adults: A systematic review and meta-analysis

    Authors: , , , - Journal of Clinical Anesthesia 2020 cited by 234

  11. Ibrutinib and Venetoclax for First-Line Treatment of CLL

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Varsha Gandhi, William G. Wierda - New England Journal of Medicine 2019 cited by 504

  12. Randomised controlled trial of WISENSE, a real-time quality improving system for monitoring blind spots during esophagogastroduodenoscopy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Gut 2019 cited by 314

  13. The Impact of Mitochondrial Dysfunction in Amyotrophic Lateral Sclerosis

    Authors: , , , , , , , , , , , , , - Cells 2022 cited by 100

  14. Phase II Study of Venetoclax Added to Cladribine Plus Low-Dose Cytarabine Alternating With 5-Azacitidine in Older Patients With Newly Diagnosed Acute Myeloid Leukemia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2022 cited by 114

  15. Calcium ion cross-linked sodium alginate hydrogels containing deferoxamine and copper nanoparticles for diabetic wound healing

    Authors: , , , , , , , , , , , , - International Journal of Biological Macromolecules 2022 cited by 118

  16. Efficacy and safety of vedolizumab and infliximab treatment for immune-mediated diarrhea and colitis in patients with cancer: a two-center observational study

    Authors: , , , , , , , , , , , , , , , , , - Journal for ImmunoTherapy of Cancer 2021 cited by 117

  17. Ablation of gut microbiota alleviates obesity-induced hepatic steatosis and glucose intolerance by modulating bile acid metabolism in hamsters

    Authors: , , , , , , , , , - Acta Pharmaceutica Sinica B 2019 cited by 199

  18. Guidelines for Reporting of Statistics for Clinical Research in Urology

    Authors: , , , , , , , , , , , , , , , - British Journal of Urology 2018 cited by 318

  19. Combined Tumor Suppressor Defects Characterize Clinically Defined Aggressive Variant Prostate Cancers

    Authors: , , , , , , , , , , , , , , - Clinical Cancer Research 2015 cited by 290

  20. α-Synuclein in salivary extracellular vesicles as a potential biomarker of Parkinson’s disease

    Authors: , , , , , , - Neuroscience Letters 2018 cited by 161

  21. Cabazitaxel plus carboplatin for the treatment of men with metastatic castration-resistant prostate cancers: a randomised, open-label, phase 1–2 trial

    Authors: , , , , , , , , , , , , , , , , - The Lancet Oncology 2019 cited by 202

  22. A mini-review of chemical composition and nutritional value of edible wild-grown mushroom from China

    Authors: , , , , , , , - Food Chemistry 2013 cited by 406

  23. Everolimus Versus Sunitinib Prospective Evaluation in Metastatic Non–Clear Cell Renal Cell Carcinoma (ESPN): A Randomized Multicenter Phase 2 Trial

    Authors: , , , , , , , , , , , , , , , - European Urology 2015 cited by 360

  24. Alterations in the human oral and gut microbiomes and lipidomics in COVID-19

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Gut 2021 cited by 298